Document |
Document Title |
WO/1995/018623A1 |
Novel compounds and libraries of compounds based on nitrogen atoms that are joined together with spanner groups include "letters", i.e. functional groups, that are attached to the nitrogen atoms, to the spanner groups or to both the nitr...
|
WO/1995/018116A1 |
Arthropodicidal compounds, compositions and use of compounds having formula (I) wherein A, E, X, Y, Z, R1, R2, R3, R4, R5, n and m are as defined in the text.
|
WO/1995/017093A1 |
The present invention provides novel cryptophycin compounds having structure (I). The present invention also provides methods for producing cryptophycins from the Nostoc sp. of blue-green algae (cyanobacteria). Pharmaceutical composition...
|
WO/1995/016676A1 |
Arthropodicidal compounds, compositions and use of compounds having formula (I), wherein Q, X, Y, R1 and m are as defined in the text.
|
WO/1995/013351A1 |
Novel bleach catalysts, a method for bleaching substrates using these catalysts and detergent compositions containing same are reported. The bleaches are of the quaternary oxaziridinium salt-type. Substrates such as fabrics may be bleach...
|
WO/1995/009848A2 |
This invention relates to dichelants, in particular compounds having two macrocyclic chelant groups linked by a bridge containing an ester or amide bond, especially compounds of formula (V) (wherein each X which may be the same or differ...
|
WO/1995/007272A1 |
A compound represented by general formula (I) or a salt thereof, having an excellent helminthicidal activity as a vermicide for humans and animals, wherein A represents appropriately substituted benzyl; Aa, B and D represent each lower a...
|
WO/1995/006643A1 |
Herbicidally active compounds of formula (I), wherein RA, X, U, W, Q, m, n and p are as defined in the text, compositions containing said compounds and methods for making and using them.
|
WO/1995/004728A1 |
New azadioxacycloalkenes have the formula (I), in which A stands for optionally substituted alkane diyl (alkylene); Ar stands for optionally substituted arylene or heteroarylene; E stands for one of the following groupings (a), (b), (c),...
|
WO/1995/001979A1 |
The present invention relates to novel heterocyclic compounds having general formula (1) wherein: X is O, S, Se, or NR2; Y1, Y2, Y3, Y4 independently are N or CR2; Z is O, S, Se, NR2 or C = N; and A is (a) or (b) wherein W is O, S, NH or...
|
WO/1994/025424A1 |
Described are fullerene derivatives of the formula (I) in which the symbols are as defined as follows: F is a fullerene unit of the formula C(20+2m) in which m = 20, 25, 28 or 29; E1 and E2, when they are the same or different, are COOH,...
|
WO/1994/019334A1 |
A novel PF1022 derivative as a cyclic depsipeptide, represented by general formula (I), or a salt thereof, having the vermifugal activity against various parasites living in man, domestic and pet animals, and the like and thus being usef...
|
WO/1994/019481A1 |
A novel compound B1371A represented by formula (I) or a novel compound B1371B represented by formula (II), each having a cysteine protease activity, a process for producing the same, and a bacterium producing the same. The compounds are ...
|
WO/1994/013660A1 |
The amount of chiral doping substances in FLC mixtures may be reduced by introducing chiral complex ligands and macrocycles into the FLC mixture or on the orientation layer.
|
WO/1994/010173A1 |
Disclosed are novel anellated triazole compounds of formula (I), in which RA, m, n, X X, V, W and Q have the meaning stated in the specification; a method of their preparation; and their use as herbicides.
|
WO/1994/003442A1 |
3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds of general formula (I) wherein R1 is the same or different groups and represents alkyl or alkoxy groups having 1 to 3 carbon atoms, halogen, trifluoromethyl, nitro, cyano, phenyl...
|
WO/1993/025543A2 |
The invention concerns the use, to control endoparasites in medical and veterinary practice, of cyclic depsipeptides with 18 ring atoms and having general formula (I), in which R?1¿ to R?6¿ are as defined in the description, plus optic...
|
WO/1993/019045A1 |
Substituted amides, agricultural compositions containing them and a method to control arthropods in agronomic and nonagronomic environments, the amides having formula (I) wherein X is oxygen or sulfur and Q, G and Y are as defined in the...
|
WO/1993/019053A1 |
A compound represented by general formula (I) or a salt thereof, excellent in parasiticidal activity as an enthelmintic for animal and man, wherein A represents benzyl which is appropriately substituted or phenyl which may be appropriate...
|
WO/1993/018038A1 |
Insecticidal compounds of the formula (I) wherein G, X, Y and Q are as defined in the text, agricultural compositions containing them and a method for using the compounds to control arthropods in agronomic and nonagronomic environments.
|
WO/1993/011117A1 |
Novel N-[2-(cyclic alkyl)phenyl]pyrazole-4-carboxamides useful as fungicides, methods of using said compounds, and fungicidal compositions containing them.
|
WO/1993/005028A1 |
Crown ether compounds which can function as receptor molecules for species such as alcohols, especially for ethanol, and other materials capable of forming hydrogen bonds. The compounds are based on 1,7-diaza-12-crown-4 group, substitute...
|
WO/1993/004142A1 |
Decomposable complex ligands may be stabilized by derivating them with blocking secondary or tertiary carbonic or sulfonic acids. Orientation layers and liquid crystal mixtures may be added to these stabilized derivates that cause in FLC...
|
WO/1992/020682A1 |
Substituted anilides of formula (I), wherein Q is one of (Q-1), (Q-2) and (Q-3), and R?1� to R?5�, Y, Z and Z?1� are as defined in the text, arthropodicidal compositions containing such compounds; and a method for controlling arthr...
|
WO/1992/013847A1 |
The present invention relates to hitherto unknown 3-substituted 1,2,3,4-oxatriazole-5-imine compounds which have proved to have biological effects making them suitable for treatment of cardiovascular diseases (blood clots), angina pector...
|
WO/1992/011249A1 |
Arthropodicidal carboxanilides of formulae (I) and (II) wherein Q, X, X?1¿, Y and G are as defined in the text, arthropodicidal compositions containing said compounds and a method for using the compounds to control arthropods.
|
WO/1991/012243A2 |
A monomer and polymers resulting therefrom, the monomer comprising (I), wherein n = 1 or 2; m = 1 or 2; R' = H or CH3; X = -O-, -CH2, -NR-; R = H, -alkyl, -aryl, -CH2(CH2)y-C = N, -CH2O alkyl, -(CH2)yOH, -CH2CH(OH)CH3 wherein y = 1 - 12;...
|
WO/1991/010655A1 |
The invention relates to partially novel metal complexes, salts and double salts of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane compounds of formula (I), wherein Q1 and Q2 mean hydrogen or a group of formula (III), in the groups of form...
|
WO/1991/009863A1 |
Organophosphorus-substituted oxadiazines (I) are disclosed which exhibit insecticidal, acaricidal and nematicidal activity, as well as compositions including such compounds, and methods for controlling insects, acarids or nematodes emplo...
|
WO/1990/014343A1 |
Pharmaceutical composition for decorporating radioactive isotopes from living organisms comprising as active agent a product prepared by reacting 1,4,10,17-tetraoxa-7,16-diazacyclooctadecane with 2-bromomalonic acid disodium salt.
|
WO/1990/007111A2 |
A molecular model of the interaction of various non beta-lactam antibiotics with the active site of a penicillin receptor has been developed so that it is now possible to predict the ''fit'' and ''reactivity'' of potential antibacterial ...
|
WO/1990/003975A1 |
A process is provided for the preparation of Mn(II) chelates for use as contrast agents in magnetic resonance imaging, said process comprising reacting insoluble manganese (II) oxide with an aqueous suspension comprising a molar equivale...
|
WO/1989/010752A1 |
A retroviral protease inhibiting compound of formula (I) or a pharmaceutically acceptable salt, prodrug or ester thereof.
|
WO/1989/000557A1 |
There are provided chelating agents particularly useful for the preparations of diagnostic and therapeutic agents for magnetic resonance imaging, scintigraphy, ultrasound imaging, radiotherapy and heavy metal detoxification, said agents ...
|
WO/1987/005030A1 |
A conjugate compound has the structure (I), wherein R1 is -(CH2)p-R6-(CH2)q- where p and q are the same or different and are 0, 1 or 2, and -R6- is -(CH2)n-, where n is 0 or 1, -NH-, -O-, -S- or (II), R1 optionally being alkyl substitute...
|
WO/1985/003078A1 |
Platinum and crown ether complexes having the general formula (I), wherein C is a mono- or bicyclic crown ether, A is ammonia or a mono- or di-Cl-C4-alkylamine or an amine function contained in the crown ether and X is halogen or the ani...
|
WO/1982/004252A1 |
N-hydroxyethylated macrocyclic polyamines of the formula (FORMULA) in which X is O or N(CH2CH2OH), and each of Y1 and Y2, which are equal or different, are (FORMULA) with the proviso that X is different from N (CH2CH2OH) when both Y1 and...
|
WO/1982/004253A1 |
New aza-crown-ethers having the general formula (FORMULA) in which a) X is oxygen and R is hydrogen, alkyl, aralkyl, aryl, alkoxyalkyl, hydroxyalkyl, alkoxycarbonylalkyl, carbamoylalkyl, nitrophenyldiazophenyl or (FORMULA) in which n is ...
|
WO/1981/002420A1 |
Betaine is recovered from natural sources such as beet molasses, rest molasses and vinasse by diluting the molasses to 25-50% solids, introducing the molasses to the top of a chromatographic column containing a salt of polystyrene sulfon...
|
JP7433226B2 |
The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
|
JP2024009811A |
The present invention provides creatine prodrug analogs and compositions thereof useful for treating creatine deficiency. [Solution] Compound of formula (I): (In the formula, R is -CH3,-CH2D,-CHD2, or -CD3;R1is straight-chain or branched...
|
JP2023184492A |
The present invention provides a compound having PLD inhibitory activity. The present invention provides a compound having the following structural formula or a pharmaceutically acceptable salt thereof. (Each symbol in the formula has th...
|
JP2023538815A |
The present invention provides methods for synthesizing various compounds by reaction of carboxamides or carboxamide derivatives with various substituted or unsubstituted haloalkanols in a one-step, single-vessel reaction mechanism. Pref...
|
JP2023115065A |
To provide dihydrooxadiazinone compounds of general formula (I) as described and defined herein, methods of preparing the compounds, pharmaceutical compositions and the use of the compounds for the treatment or prophylaxis of diseases, i...
|
JP2023521351A |
The present invention relates to macrocyclic diamine derivatives of formula II, including pharmaceutically acceptable salts and solvates thereof. The compounds of the invention are inhibitors of ENT family transporters, particularly ENT1...
|
JP2023518512A |
The present invention relates to compounds of formula (I) and their use as herbicides. In the above formula, R1~R7represents a group such as hydrogen, halogen or an organic group such as alkyl, alkenyl, alkynyl or alkoxy, X is a bond or ...
|
JP7260564B2 |
The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereofwherein each of R1, R2, R3, R4, L1, and L2 are as defined herein. The present invention also contemplates c...
|
JP2023508159A |
The present invention provides a tetrahydrobenzo-isoquinoline sulfonamide derivative of formula (I), [Chemical 1] Methods for their preparation, pharmaceutical compositions containing them, and disorders caused by IgE (such as allergic r...
|
JP7198269B2 |
Compounds are provided that are useful as immunomodulators. The compounds have the following Formula (I) or (II):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, R1, R2a, R2b, R2c, R3, R4, R5, R6a, R6b, R...
|
JP2022535802A |
The present invention provides a compound of formula (I) or its pharmaceutical composition for use in the prevention and/or treatment of conditions associated with proinflammatory conditions, diseases associated with oxidative stress or ...
|